186 related articles for article (PubMed ID: 24763284)
21. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma.
Ding MX; Lin XQ; Fu XY; Zhang N; Li JC
World J Gastroenterol; 2006 Jul; 12(28):4582-5. PubMed ID: 16874878
[TBL] [Abstract][Full Text] [Related]
22. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
24. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
[TBL] [Abstract][Full Text] [Related]
25. Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis.
Liu S; Zhang S; Jiang H; Yang Y; Jiang Y
Med Oncol; 2013; 30(3):636. PubMed ID: 23797770
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy.
Okumura H; Uchikado Y; Matsumoto M; Owaki T; Kita Y; Omoto I; Sasaki K; Sakurai T; Setoyama T; Nabeki B; Matsushita D; Ishigami S; Hiraki Y; Nakajo M; Natsugoe S
Int J Clin Oncol; 2013 Apr; 18(2):329-34. PubMed ID: 22350023
[TBL] [Abstract][Full Text] [Related]
27. TRAP1 shows clinical significance and promotes cellular migration and invasion through STAT3/MMP2 pathway in human esophageal squamous cell cancer.
Ou Y; Liu L; Xue L; Zhou W; Zhao Z; Xu B; Song Y; Zhan Q
J Genet Genomics; 2014 Oct; 41(10):529-37. PubMed ID: 25438697
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray.
Sang M; Gu L; Liu F; Lian Y; Yin D; Fan X; Ding C; Huang W; Liu S; Shan B
Arch Med Res; 2016 Apr; 47(3):151-61. PubMed ID: 27362547
[TBL] [Abstract][Full Text] [Related]
29. Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development.
Sato S; Yamamoto H; Mukaisho K; Saito S; Hattori T; Yamamoto G; Sugihara H
PLoS One; 2014; 9(2):e88831. PubMed ID: 24551170
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of perineural, blood and lymph vessel invasion for esophageal cancer.
Tachezy M; Tiebel AK; Gebauer F; Kutup A; Tharun L; Pantel K; Izbicki JR; Vashist YK
Histol Histopathol; 2014 Nov; 29(11):1467-75. PubMed ID: 24819775
[TBL] [Abstract][Full Text] [Related]
31. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
Wang XB; Jiang XR; Yu XY; Wang L; He S; Feng FY; Guo LP; Jiang W; Lu SH
Cancer Sci; 2014 Feb; 105(2):176-85. PubMed ID: 24383865
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of venous invasion and maximum standardized uptake value of
Jeon JH; Lee JM; Moon DH; Yang HC; Kim MS; Lee GK; Zo JI
Eur J Surg Oncol; 2017 Feb; 43(2):471-477. PubMed ID: 27912930
[TBL] [Abstract][Full Text] [Related]
33. The Role of Maximum Standardized Uptake Value in PET/CT as a Prognostic Factor in Patients with Resected Esophageal Squamous Cell Carcinoma.
Song IH; Cho S; Yang HC; Jheon S
Thorac Cardiovasc Surg; 2015 Jun; 63(4):335-40. PubMed ID: 25068775
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
35. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
[TBL] [Abstract][Full Text] [Related]
36. Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.
Zhang Y; Zhang YL; Chen HM; Pu HW; Ma WJ; Li XM; Ma H; Chen X
World J Gastroenterol; 2014 May; 20(18):5533-9. PubMed ID: 24833884
[TBL] [Abstract][Full Text] [Related]
37. A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis.
Cao HH; Zheng CP; Wang SH; Wu JY; Shen JH; Xu XE; Fu JH; Wu ZY; Li EM; Xu LY
PLoS One; 2014; 9(8):e106007. PubMed ID: 25153136
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
[TBL] [Abstract][Full Text] [Related]
39. Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.
Yang Q; Luo GY; Li Y; Shan HB; Wang HY; Xu GL
Med Oncol; 2013 Dec; 30(4):689. PubMed ID: 24026656
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.
Son SW; Kim SH; Moon EY; Kim DH; Pyo S; Um SH
Oncotarget; 2016 Aug; 7(31):49334-49348. PubMed ID: 27384996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
